Abstract
1 The effects of sodium valproate on the performance of a series of psychological tests and mood was studied. 2 Ten healthy male volunteers received sodium valproate and placebo, each for a period of 2 weeks, in a double-blind cross-over design. Dosage of sodium valproate was increased to 800 mg/day in the first week and to 1 g/day in the second week of treatment. 3 Psychological testing took place on three occasions, before and on completion of each of the two treatment periods. 4 The few significant differences between drug and placebo conditions indicated impairment on sodium valproate. 5 The findings are discussed in relation to those from a similarly designed study of the anticonvulsant phenytoin. Implications for epilepsy are also considered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boxer C. M., Herzberg J. L., Scott D. F. Has sodium valproate hypnotic effects? Epilepsia. 1976 Dec;17(4):367–370. doi: 10.1111/j.1528-1157.1976.tb04447.x. [DOI] [PubMed] [Google Scholar]
- Dodrill C. B. Diphenylhydantoin serum levels, toxicity, and neuropsychological performance in patients with epilepsy. Epilepsia. 1975 Nov;16(4):593–600. doi: 10.1111/j.1528-1157.1975.tb04741.x. [DOI] [PubMed] [Google Scholar]
- Dodrill C. B., Troupin A. S. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology. 1977 Nov;27(11):1023–1028. doi: 10.1212/wnl.27.11.1023. [DOI] [PubMed] [Google Scholar]
- Haigh D., Forsythe W. I. The treatment of childhood epilepsy with sodium valproate. Dev Med Child Neurol. 1975 Dec;17(6):743–748. doi: 10.1111/j.1469-8749.1975.tb04698.x. [DOI] [PubMed] [Google Scholar]
- Jeavons P. M., Clark J. E. Sodium valproate in treatment of epilepsy. Br Med J. 1974 Jun 15;2(5919):584–586. doi: 10.1136/bmj.2.5919.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lishman W. A. Selective facotrs in memory. 2. Affective disorder. Psychol Med. 1972 Aug;2(3):248–253. doi: 10.1017/s0033291700042549. [DOI] [PubMed] [Google Scholar]
- MCNAIR D. M., LORR M. AN ANALYSIS OF MOOD IN NEUROTICS. J Abnorm Psychol. 1964 Dec;69:620–627. doi: 10.1037/h0040902. [DOI] [PubMed] [Google Scholar]
- Rosen J. A. Dilantin dementia. Trans Am Neurol Assoc. 1968;93:273–273. [PubMed] [Google Scholar]
- Sommerbeck K. W., Theilgaard A., Rasmussen K. E., Lohren V., Gram L., Wulff K. Valproate sodium: evaluation of so-called psychotropic effect. A controlled study. Epilepsia. 1977 Jun;18(2):159–167. doi: 10.1111/j.1528-1157.1977.tb04464.x. [DOI] [PubMed] [Google Scholar]
- Völzke E., Doose H. Dipropylacetate (Dépakine, Ergenyl) in the treatment of epilepsy. Epilepsia. 1973 Jun;14(2):185–193. doi: 10.1111/j.1528-1157.1973.tb03955.x. [DOI] [PubMed] [Google Scholar]